Penserra Capital Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $327K | Sell |
4,748
-3,083
| -39% | -$212K | ﹤0.01% | 560 |
|
|
2025
Q1 | $543K | Buy |
7,831
+1,794
| +30% | +$124K | 0.01% | 580 |
|
|
2024
Q4 | $519K | Buy |
6,037
+618
| +11% | +$53.1K | 0.01% | 559 |
|
|
2024
Q3 | $645K | Sell |
5,419
-40,913
| -88% | -$4.87M | 0.01% | 497 |
|
|
2024
Q2 | $6.61M | Buy |
46,332
+15,762
| +52% | +$2.25M | 0.08% | 196 |
|
|
2024
Q1 | $3.92M | Buy |
30,570
+23,006
| +304% | +$2.95M | 0.05% | 259 |
|
|
2023
Q4 | $782K | Sell |
7,564
-20,769
| -73% | -$2.15M | 0.01% | 422 |
|
|
2023
Q3 | $2.58M | Buy |
+28,333
| New | +$2.58M | 0.05% | 231 |
|
|
2023
Q2 | – | Sell |
-8,052
| Closed | -$640K | – | 1300 |
|
|
2023
Q1 | $640K | Buy |
8,052
+5,856
| +267% | +$465K | 0.01% | 446 |
|
|
2022
Q4 | $148K | Buy |
2,196
+1,464
| +200% | +$98.7K | ﹤0.01% | 745 |
|
|
2022
Q3 | $36K | Buy |
+732
| New | +$36K | ﹤0.01% | 841 |
|